P. Markus Deckert

1.1k total citations
44 papers, 838 citations indexed

About

P. Markus Deckert is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, P. Markus Deckert has authored 44 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in P. Markus Deckert's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). P. Markus Deckert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). P. Markus Deckert collaborates with scholars based in Germany, United States and Switzerland. P. Markus Deckert's co-authors include H. Poliwoda, Jens Atzpodien, Hartmut Kirchner, Enrique Lopez Hänninen, Martin Fenner, Hendrik Fuchs, Christopher Bachran, Guido Reifenberger, Diana Bachran and Reinhard Prior and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

P. Markus Deckert

41 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Markus Deckert Germany 16 323 256 163 135 127 44 838
Zélia M. Corrêa United States 21 430 1.3× 424 1.7× 117 0.7× 324 2.4× 185 1.5× 127 1.4k
Stéphanie Meier Germany 14 317 1.0× 314 1.2× 250 1.5× 39 0.3× 95 0.7× 22 910
Quan P. Ly United States 19 331 1.0× 405 1.6× 141 0.9× 45 0.3× 121 1.0× 42 922
Srdjan Novaković Slovenia 22 557 1.7× 292 1.1× 91 0.6× 75 0.6× 151 1.2× 114 1.3k
Eugenie Kleinerman United States 15 369 1.1× 249 1.0× 176 1.1× 55 0.4× 297 2.3× 24 783
Jianying Gu China 18 427 1.3× 246 1.0× 90 0.6× 184 1.4× 116 0.9× 47 923
Pavel Klener Czechia 25 631 2.0× 638 2.5× 137 0.8× 75 0.6× 266 2.1× 121 1.6k
Christine Alewine United States 18 295 0.9× 517 2.0× 299 1.8× 188 1.4× 395 3.1× 51 1.1k
Mumtaz V. Rojiani United States 14 537 1.7× 169 0.7× 101 0.6× 60 0.4× 121 1.0× 29 931
David Tacha United States 19 342 1.1× 364 1.4× 362 2.2× 64 0.5× 88 0.7× 37 1.1k

Countries citing papers authored by P. Markus Deckert

Since Specialization
Citations

This map shows the geographic impact of P. Markus Deckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Markus Deckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Markus Deckert more than expected).

Fields of papers citing papers by P. Markus Deckert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Markus Deckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Markus Deckert. The network helps show where P. Markus Deckert may publish in the future.

Co-authorship network of co-authors of P. Markus Deckert

This figure shows the co-authorship network connecting the top 25 collaborators of P. Markus Deckert. A scholar is included among the top collaborators of P. Markus Deckert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Markus Deckert. P. Markus Deckert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Goerling, Ute, Ulrike Grittner, Andreas Meisel, et al.. (2023). Feasibility of a patient-oriented navigation programme for patients with lung cancer or stroke in Germany: Protocol of the CoreNAVI study. PLoS ONE. 18(6). e0287638–e0287638. 3 indexed citations
3.
Bachran, Diana, et al.. (2012). Targeted Tumor Therapy With a Fusion Protein of an Antiangiogenic Human Recombinant scFv and Yeast Cytosine Deaminase. Journal of Immunotherapy. 35(7). 570–578. 3 indexed citations
4.
Romeike, Bernd, et al.. (2009). Persistent toxoplasma bradyzoite cysts in the brain: incidental finding in an immunocompetent patient without evidence of a toxoplasmosis. Clinical Neuropathology. 28(5). 210–212. 24 indexed citations
5.
Deckert, P. Markus. (2009). Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy. Current Drug Targets. 10(2). 158–175. 62 indexed citations
6.
Frey, Dietmar, Vânia Coelho, Ulf Petrausch, et al.. (2008). Surface Expression of gpA33 is Dependent on Culture Density and Cell-Cycle Phase and is Regulated by Intracellular Traffic Rather than Gene Transcription. Cancer Biotherapy and Radiopharmaceuticals. 23(1). 65–73. 6 indexed citations
7.
Coelho, Vânia, Jens Dernedde, Hendrik Fuchs, et al.. (2008). Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatants. Bioprocess and Biosystems Engineering. 31(6). 559–568. 12 indexed citations
8.
Petrausch, Ulf, Jens Dernedde, Verônica Coelho, et al.. (2007). A33scFv Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting. Protein Engineering Design and Selection. 20(12). 583–590. 11 indexed citations
9.
Siehl, Jan, Eckhard Thiel, Alexander Schmittel, et al.. (2005). Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma. Cancer. 104(3). 611–617. 21 indexed citations
10.
Deckert, P. Markus, Christoph Renner, Lawrence Cohen, et al.. (2003). A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy. British Journal of Cancer. 88(6). 937–939. 31 indexed citations
11.
Glasmacher, Axel, Hendrik Pels, Christoph Helmstaedter, et al.. (2001). Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: Superior results in patients younger than 60 years. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
12.
Radner, H., D. Katenkamp, G. Reifenberger, et al.. (2001). New developments in the pathology of skull base tumors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 438(4). 321–335. 30 indexed citations
13.
Deckert, P. Markus, Matthias Ballmaier, Stephan Lang, H. Deicher, & I. Schedel. (1996). CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. The Journal of Immunology. 156(2). 826–833. 12 indexed citations
14.
Deckert, P. Markus, Anke Franzke, Jan Buer, et al.. (1996). Linomide and Interleukin-2 in Patients with Advanced Renal Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 11(5). 319–324.
15.
Hänninen, Enrique Lopez, Thomas Menzel, A. Schomburg, et al.. (1994). In Vivo Time and Dose Dependency of Interleukin-6 Secretion in Response to Low-Dose Subcutaneous Recombinant Interleukin-2. PubMed. 9(4). 307–316. 9 indexed citations
16.
Atzpodien, Jens, Hartmut Kirchner, Enrique Lopez Hänninen, et al.. (1994). Treatment of Metastatic Colorectal Cancer Patients with 5-Fluorouracil in Combination with Recombinant Subcutaneous Human lnterleukin-2 and Alpha-lnterferon. Oncology. 51(3). 273–275. 4 indexed citations
17.
Atzpodien, Jens, Hartmut Kirchner, Enrique Lopez Hänninen, et al.. (1993). Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer. European Journal of Cancer. 29. S6–S8. 111 indexed citations
18.
19.
Hänninen, E Lopez, Martin Fenner, Hartmut Kirchner, et al.. (1993). Limited Efficacy of Interferon-α and Vinblastine as Second Line Biochemotherapy Regimen in Patients with Progressive Metastatic Renal Cell Carcinoma. PubMed. 8(4). 301–306. 4 indexed citations
20.
Reifenberger, Guido, Reinhard Prior, P. Markus Deckert, & W. Wechsler. (1989). Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 414(2). 147–155. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zélia M. Corrêa Breakdown of academic impact, for papers by Stéphanie Meier Breakdown of academic impact, for papers by Quan P. Ly Breakdown of academic impact, for papers by Srdjan Novaković Breakdown of academic impact, for papers by Eugenie Kleinerman Breakdown of academic impact, for papers by Jianying Gu Breakdown of academic impact, for papers by Pavel Klener Breakdown of academic impact, for papers by Christine Alewine Breakdown of academic impact, for papers by Mumtaz V. Rojiani Breakdown of academic impact, for papers by David Tacha
Rankless by CCL
2026